Current Topics in Medicinal Chemistry

Editor-in-Chief:

Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
USA

Back

Editorial [Hot Topic: Benefits, Problems and Alternatives to COX-2 Inhibition (Guest Editor: Angel Lanas)] promotion: free to download

Volume:5   Issue:5
Pp: 441-442
A. Lanas
DOI: 10.2174/1568026054201622

Global Safety of Coxibs and NSAIDs

Volume:5   Issue:5
Pp: 465-473
K. Pham and R. Hirschberg
DOI: 10.2174/1568026054201640

COX Inhibition and NSAID-Induced Gastric Damage - Roles in Various Pathogenic Events

Volume:5   Issue:5
Pp: 475-486
K. Takeuchi, A. Tanaka, Y. Hayashi and A. Yokota
DOI: 10.2174/1568026054201668

Dual COX-Inhibitors: The Answer is NO?

Volume:5   Issue:5
Pp: 487-492
S. Fiorucci and E. Antonelli
DOI: 10.2174/1568026054201677

Low Dose Aspirin, COX-Inhibition and Chemoprevention of Colorectal Cancer

Volume:5   Issue:5
Pp: 493-503
R. Benamouzig, B. Uzzan, J. Little and S. Chaussade
DOI: 10.2174/1568026054201631

Mechanisms of Colon Cancer Prevention with and Beyond COX-2 Inhibition

Volume:5   Issue:5
Pp: 505-516
F. Rodriguez-Moranta and A. Castells
DOI: 10.2174/1568026054201686

Chemoprevention of Colorectal Cancer: Ready for Routine Use?

Volume:5   Issue:5
Pp: 517-525
N. Arber and B. Levin
DOI: 10.2174/1568026054201659